Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Pre-Solicitation opportunity from Department Of Veterans Affairs was posted on July 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Glipizide Tablets

Closed
36E79726R0031Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Department of Veterans Affairs, through the National Acquisition Center, plans to award a single indefinite-delivery, indefinite-quantity contract for Glipizide Tablets to ensure an uninterrupted supply for VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center facilities. The contract will have a one-year base period with four one-year option periods, and the product will be distributed via the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under a unique NDC number assigned exclusively to them, with their label being the only label on the product; VA labeling must be able to securely adhere over the contractor’s label without overlapping or covering existing labels. All tablets must be packaged in unit-of-use bottles with specific physical requirements: cylindrical shape, minimum 120cc volume, 5.75-inch circumference, and a label space of 5.25 x 2 inches with an additional 0.5 inches reserved for barcodes and expiration dates. Bottles must include a safety cap that can be converted to a non-safety cap and must not exceed the bottle’s diameter. The solicitation will be issued electronically on or about July 27, 2026, with responses due by August 10, 2026, under FAR Part 12 as a commercial item procurement. The NAICS code is 325412, and only electronic access via SAM.gov is available—no paper copies or phone requests will be honored. Estimated annual demand includes multiple package sizes for both 5mg and 10mg tablets, with bottle volumes of 90, 180, and 360 counts for unit-of-use packaging, and bulk options of 500 or 1,000 tablets for non-unit-of-use needs, totaling over 300,000 bottles annually. The primary point of contact is Contract Specialist Deb Fassl, reachable via email at Deborah.Fassl@va.gov, and potential offerors must monitor SAM.gov regularly for amendments or updates. All responsible sources are invited to submit offers, and submissions received on time will be considered without restriction.

General Info

VA seeks single contractor for Glipizide Tablets with strict packaging, NDC, and delivery requirements via Prime Vendor Programs.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

(1)

36E79726R0031_1.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Organization / Agency
Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
View Agency Profile
Office AddressHINES, IL, 60141, USA
Contacts
Deb FasslContract Specialist

Full Description

Show more
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0031 for an unrestricted procurement for Glipizide Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label. This product requires unit of use packaging, as identified in the Schedule of Supplies (e.g., 90, 180, and 360 count bottles). The bottles shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation #36E79726R0031 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about July 27, 2026, with a tentative closing date of August 10, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to Deborah.Fassl@va.gov. The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION ITEM DESCRIPTION UNIT of USE
PKG. SIZE (Tablets per Bottle) TOTAL EST. ANNUAL USAGE (Bottles) 1 GLIPIZIDE 5MG TAB Y 90 60,691 2 GLIPIZIDE 5MG TAB Y 180 58,708 3a GLIPIZIDE 5MG TAB N 500 50,084 OR 3b GLIPIZIDE 5MG TAB N 1000 25,042 4 GLIPIZIDE 10MG TAB Y 90 26,156 5 GLIPIZIDE 10MG TAB Y 180 88,612 6 GLIPIZIDE 10MG TAB Y 360 18,238 7a GLIPIZIDE 10MG TAB N 500 57,870 OR 7b GLIPIZIDE 10MG TAB N 1000 28,935

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Ticagrelor Tablets
Solicitation # 36E79726R0028
The Department of Veterans Affairs National Acquisition Center is seeking an unrestricted procurement to establish an uninterrupted source of supply for Ticagrelor Tablets. This firm-fixed-price, indefinite-delivery requirements contract supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The award is designated as a HUBZONE small business set-aside and will be granted to the lowest-priced, technically acceptable offeror. The contract structure consists of a base year and four one-year options, with a maximum 60-calendar day implementation period before the ordering period begins. The scope of work includes the supply of Ticagrelor in 60mg and 90mg strengths across various bottle sizes, ranging from 60 to 1,000 tablets. Strict packaging and labeling standards are required, including the use of cylindrical bottles with a minimum 120cc volume and 5.75 inch circumference, safety caps that are convertible or deshelled, and unique 11-digit NDC numbers. All products must be compatible with automated dispensing units and feature GS1-128 or HIBC linear bar codes, as well as two-dimensional data matrix bar codes per the Drug Supply Chain Security Act. To be eligible for award, offerors must maintain an acceptable FDA cGMP status for their manufacturing facilities and provide the necessary NDA, ANDA, or BLA clearances. Those who are not the manufacturer must provide a formal Letter of Commitment ensuring a sufficient source of supply. Distribution will be managed through Government Prime Vendor contracts, with deliveries made to approximately 56 VA and DoD distribution centers nationwide. Proposals must be submitted in PDF or Word format, including a signed SF-1449 and pricing for all line items across the base and option years, with prices held firm for 120 calendar days.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
Federal
6505--2027-2028 Influenza Virus Vaccine
Solicitation # 36E79726R0035
Solicitation 36E79726R0035 is an unrestricted FAR Part 12 commercial-item procurement issued by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccines for the 2027-2028 season. The contract requires the delivery of trivalent or quadrivalent vaccines in pre-filled single-dose syringes with plunger and Luer lock needle attachments, provided in boxes of 10. The vaccines must be latex and preservative free, with specific FDA approval and labeling required for pediatric populations (6 to 35 months) and seniors (65 years and older). Final vaccine presentation is based on World Health Organization recommendations, with a preference for Trivalent presentations if both Trivalent and Quadrivalent options are commercially available. The award will be made on a per solicitation line item basis for the VA, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. Deliveries are Free On Board Destination to government facilities across the United States, Puerto Rico, and the Philippines. Most facilities require a two-part delivery schedule, with at least 50 percent of the order delivered between August 15 and September 15, 2027, and the remainder by October 15, 2027; however, the FHCC must receive 100 percent of its awarded quantity by September 15, 2027. Offerors must provide the full quantity for any line item bid, and final pricing must include the Cost Recovery Fee and Federal Excise Tax.
Pharmaceutical Preparation Manufacturing

POSTED

4 days ago

DEADLINE

in 11 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS